Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ngoc-Vu Vu Nguyen"'
Autor:
Hong-Anh Thi Pham, Hoa Giang, Anh-Thu Huynh Dang, Hoai-Nghia Nguyen, Hong-Thuy Thi Dao, Luan Thanh Nguyen, Han Ngoc Do, Thanh-Thuy Thi Do, Thai-Hoa Thi Nguyen, Lam Nhat Nguyen, Chu Van Nguyen, Mai-Lan Thi Nguyen, Ha Thu Le, Long Hung Nguyen, Kiet Truong Dinh, Thien-Chi Van Nguyen, Vu Thuong Le, Phuc Huu Nguyen, Ngoc-Vu Vu Nguyen, Quynh-Tho Thi Nguyen, Minh-Duy Phan, Nguyen Huu Nguyen, Binh Thanh Vo, Dinh-Thong Vu Le, Le Son Tran, Vu-Uyen Tran, Quynh-Tram Nguyen Bui, Thanh-Truong Tran, Truong Xuan Le
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Comprehensive profiling of actionable mutations in non-small cell lung cancer (NSCLC) is vital to guide targeted therapy, thereby improving the survival rate of patients. Despite the high incidence and mortality rate of NSCLC in Vietnam, the actionab
Autor:
Chu Van Nguyen, Anh-Thu Huynh Dang, Hong-Thuy Thi Dao, Son-Lam Vu Nguyen, Phuong Cam Pham, Le Son Tran, Thanh-Truong Tran, Hong-Anh Thi Pham, Dinh-Thong Vu Le, Thanh-Thuy Thi Do, Trieu-Vu Nguyen, Vu-Uyen Tran, Kiet Truong Dinh, Tam Tran, Thien Kim Dinh-Nguyen, Hoa Giang, Anh Tuan Dang-Mai, Nguyen Huu Nguyen, Binh Thanh Vo, Hoai-Nghia Nguyen, Van Hieu Phan, Minh-Duy Phan, Ngoc-Vu Vu Nguyen, Han Ngoc Do
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226193 (2019)
PLoS ONE
PLoS ONE
The identification and quantification of actionable mutations are of critical importance for effective genotype-directed therapies, prognosis and drug response monitoring in patients with non-small-cell lung cancer (NSCLC). Although tumor tissue biop
Autor:
Thanh-Truong Tran, Han Ngoc Do, Vu Trieu Nguyen, Anh-Thu Huynh Dang, Minh-Duy Phan, Chu Van Nguyen, Cam Phuong Pham, Nguyen Huu Nguyen, Binh Thanh Vo, Hong-Anh Thi Pham, Son-Lam Vu Nguyen, Le Son Tran, Dinh-Thong Vu Le, Hoa Giang, Uyen Vu Tran, Ngoc-Vu Vu Nguyen, Kiet Truong Dinh, Thuy Thanh Do, Hoai-Nghia Nguyen
Publikováno v:
Journal of Global Oncology. 5:54-54
54 Background: Non-small cell lung cancer (NSCLC) is the most common subtype of lung cancer and leading cause of cancer related death worldwide. Acquired genetic alterations in major driver genes including EGFR, KRAS, NRAS, BRAF, ALK and ROS1 are the
Autor:
Chu Van Nguyen, Cam Phuong Pham, Hoa Giang, Kiet Truong Dinh, Vu Trieu Nguyen, Le Son Tran, Dinh-Thong Vu Le, Son-Lam Vu Nguyen, Hong-Anh Thi Pham, Anh-Thu Huynh Dang, Thien Kim Dinh-Nguyen, Uyen Vu Tran, Thanh-Truong Tran, Van Hieu Phan, Anh Tuan Dang-Mai, Nguyen Huu Nguyen, Binh Thanh Vo, Ngoc-Vu Vu Nguyen, Thuy Thanh Do, Hoai-Nghia Nguyen
Publikováno v:
Journal of Global Oncology. 5:55-55
55 Background: The identification and quantification of actionable mutations are of critical importance for effective genotype-directed therapies, prognosis and drug response monitoring in patients with non-small-cell lung cancer (NSCLC). Although tu